<DOC>
	<DOCNO>NCT00308321</DOCNO>
	<brief_summary>Parallel group double blind randomise patient first episode corticosteroid sensitive nephrotic syndrome comparing time relapse adverse effect associate longer taper steroid regimen standard regime</brief_summary>
	<brief_title>Long Term Tapering Standard Steroids Nephrotic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Nephrotic Syndrome</mesh_term>
	<mesh_term>Nephrosis</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>newly present nephrotic syndrome , urine albumin/protein creatinine ratio &gt; 200mg/mmol early morning urine sample , hypoalbuminemia ( &lt; 25g/L ) prior treatment steroid cytotoxic agent underlie systemic disorder exposure agent know associated newly present steroid sensitive nephrotic syndrome</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>